These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25036566)

  • 1. Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout.
    Aati O; Taylor WJ; Horne A; Dalbeth N
    J Clin Rheumatol; 2014 Aug; 20(5):251-5. PubMed ID: 25036566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).
    Aati O; Taylor WJ; Siegert RJ; Horne A; House ME; Tan P; Drake J; Stamp LK; Dalbeth N
    Ann Rheum Dis; 2015 Dec; 74(12):2144-50. PubMed ID: 25114061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tophaceous joint disease strongly predicts hand function in patients with gout.
    Dalbeth N; Collis J; Gregory K; Clark B; Robinson E; McQueen FM
    Rheumatology (Oxford); 2007 Dec; 46(12):1804-7. PubMed ID: 17982165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and disability in patients with treatment-failure gout.
    Becker MA; Schumacher HR; Benjamin KL; Gorevic P; Greenwald M; Fessel J; Edwards L; Kawata AK; Frank L; Waltrip R; Maroli A; Huang B; ; Sundy JS
    J Rheumatol; 2009 May; 36(5):1041-8. PubMed ID: 19332629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gouty tophus: a review.
    Chhana A; Dalbeth N
    Curr Rheumatol Rep; 2015 Mar; 17(3):19. PubMed ID: 25761926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe gout: Strategies and innovations for effective management.
    Pascual E; Andrés M; Vázquez-Mellado J; Dalbeth N
    Joint Bone Spine; 2017 Oct; 84(5):541-546. PubMed ID: 27932279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress on diagnosis and treatment of tophus].
    Ran B; Wei J
    Zhongguo Gu Shang; 2017 Sep; 30(9):876-880. PubMed ID: 29455494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
    McDonald E; Marino C
    Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing gout: there's more we can do.
    Mead T; Arabindoo K; Smith B
    J Fam Pract; 2014 Dec; 63(12):707-13. PubMed ID: 25486309
    [No Abstract]   [Full Text] [Related]  

  • 10. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.
    Dalbeth N; Petrie KJ; House M; Chong J; Leung W; Chegudi R; Horne A; Gamble G; McQueen FM; Taylor WJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1605-12. PubMed ID: 22034122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in the management of gout.
    Keith MP; Gilliland WR
    Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of plain radiography for assessing hypouricemic treatment response in patients with tophaceous gout.
    Suh YS; Cheon YH; Kim JE; Kim JM; Kim SH; Lee WS; Yoo WH; Lee SI; Kim HO
    Int J Rheum Dis; 2016 Nov; 19(11):1183-1188. PubMed ID: 27514938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free-flap resurfacing of tissue defects in the foot due to large gouty tophi.
    Lin CT; Chang SC; Chen TM; Dai NT; Fu JP; Deng SC; Tzeng YS; Chen SG
    Microsurgery; 2011 Nov; 31(8):610-5. PubMed ID: 22009664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy.
    Cao C; Gamble G; Horne A; Aati O; Doyle A; Drake J; Stamp LK; Dalbeth N
    Rheumatology (Oxford); 2024 May; 63(6):1539-1542. PubMed ID: 37688559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enquiry into the crippling gout affecting Pacific Islander and Māori men in Western Sydney.
    Coleman W; Spencer D; Wong P; Manolios N
    Int J Rheum Dis; 2021 Nov; 24(11):1394-1401. PubMed ID: 34611996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of tophaceous gout.
    Yu JS; Chung C; Recht M; Dailiana T; Jurdi R
    AJR Am J Roentgenol; 1997 Feb; 168(2):523-7. PubMed ID: 9016240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tophaceous gout: quantitative evaluation by direct physical measurement.
    Schumacher HR; Becker MA; Palo WA; Streit J; MacDonald PA; Joseph-Ridge N
    J Rheumatol; 2005 Dec; 32(12):2368-72. PubMed ID: 16331766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of tophaceous gout: When medication is not enough.
    Kasper IR; Juriga MD; Giurini JM; Shmerling RH
    Semin Arthritis Rheum; 2016 Jun; 45(6):669-74. PubMed ID: 26947439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited knee joint range of motion due to invisible gouty tophi.
    Yu KH; Lien LC; Ho HH
    Rheumatology (Oxford); 2004 Feb; 43(2):191-4. PubMed ID: 12949254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case study: a case of debilitating gout in the 1st metatarsophalangeal joint.
    Tanner N; Diaper R; King M; Metcalfe SA
    Foot (Edinb); 2015 Mar; 25(1):45-50. PubMed ID: 25724345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.